Neuronetics (STIM) Reports In-Line Q3 EPS ; Offers Guidance

Neuronetics (NASDAQ: STIM) reported Q3 EPS of ($0.13), in-line with the analyst estimate of ($0.13). Revenue for the quarter came in at $21.8 million versus the consensus estimate of $37.85 million.

GUIDANCE:

Neuronetics sees Q4 2025 revenue of $40-80 million, versus the consensus of $43.06 million.

Neuronetics sees FY2025 revenue of $147-150 million, versus the consensus of $151 million.

For earnings history and earnings-related data on Neuronetics (STIM) click here.

You May Also Be Interested In

• Lennar Corp. (LEN) Misses Q2 EPS by 1c
• First Advantage to join S&P SmallCap 600, replacing Kennedy-Wilson
• Goldman Sachs Upgrades New Oriental Education (EDU) to Buy